Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AMS Bulking Out Stress Incontinence Offerings Via UroVive Acquisition

This article was originally published in The Gray Sheet

Executive Summary

American Medical Systems and UroSurge expect to complete by year-end a modular premarket approval application submission for the UroVive urethral bulking agent system. AMS agreed to acquire the product from UroSurge on July 26.

You may also be interested in...

AMS' Planned IPO Proceeds To Pay Down Debt, Complete Influence Payments

A planned initial public offering by American Medical Systems Holdings, Inc., maker of urological disorder treatment devices, is anticipated to raise $68.8 mil. -including $40 mil. tabbed to "repay all of the outstanding debt under the guaranteed portion" of a $115 mil. credit facility.

COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers

First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts